Literature DB >> 20686478

Prescription drug abuse: insight into the epidemic.

S H Hernandez1, L S Nelson.   

Abstract

The emergence of clinically efficacious prescription drugs to treat pain, anxiety, and learning disorders is accompanied by the potential for nonmedical use. Prescription drug abuse has become a modern-day epidemic in the United States and is now second only to marijuana use across all age groups. This article reviews the various data collection, analysis, and reporting systems that have been developed in response to the growing concern for nonmedical prescription drug use. The terminology used to categorize prescription drugs that are abused and the various definitions for abuse, misuse, and nonmedical use are discussed. The epidemiology of nonmedical prescription drug use and an overview of each class of prescription drug that is at risk for nonmedical use are presented along with details of specific drugs that are associated with significant morbidity or mortality.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20686478     DOI: 10.1038/clpt.2010.154

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  40 in total

1.  The effects of North Carolina's prescription drug monitoring program on the prescribing behaviors of the state's providers.

Authors:  Chris Ringwalt; Mariana Garrettson; Apostolos Alexandridis
Journal:  J Prim Prev       Date:  2015-04

Review 2.  Harmonizing post-market surveillance of prescription drug misuse: a systematic review of observational studies using routinely collected data (2000-2013).

Authors:  Bianca Blanch; Nicholas A Buckley; Leigh Mellish; Andrew H Dawson; Paul S Haber; Sallie-Anne Pearson
Journal:  Drug Saf       Date:  2015-06       Impact factor: 5.606

3.  The impact of a theory-based web-intervention on the intention to use prescription drugs for non-medical purposes among college students: a randomized controlled trial.

Authors:  Rasha M Arabyat; Matthew Borrego; Ajna Hamidovic; Betsy Sleath; Dennis W Raisch
Journal:  Health Educ Res       Date:  2019-04-01

4.  Separate and combined psychopharmacological effects of alprazolam and oxycodone in healthy volunteers.

Authors:  James P Zacny; Judith A Paice; Dennis W Coalson
Journal:  Drug Alcohol Depend       Date:  2012-02-25       Impact factor: 4.492

Review 5.  Dependence and addiction during chronic opioid therapy.

Authors:  David N Juurlink; Irfan A Dhalla
Journal:  J Med Toxicol       Date:  2012-12

6.  Association Between Nonmedical Use of Prescription Drugs and Sleep Quality in a Large College Student Sample.

Authors:  Yahya A Alamir; Keith J Zullig; Sijin Wen; Hawley Montgomery-Downs; Alfgeir L Kristjansson; Ranjita Misra; Jianjun Zhang
Journal:  Behav Sleep Med       Date:  2017-12-22       Impact factor: 2.964

Review 7.  Determinants of increased opioid-related mortality in the United States and Canada, 1990-2013: a systematic review.

Authors:  Nicholas B King; Veronique Fraser; Constantina Boikos; Robin Richardson; Sam Harper
Journal:  Am J Public Health       Date:  2014-06-12       Impact factor: 9.308

8.  Can we build an efficient response to the prescription drug abuse epidemic? Assessing the cost effectiveness of universal prevention in the PROSPER trial.

Authors:  D Max Crowley; Damon E Jones; Donna L Coffman; Mark T Greenberg
Journal:  Prev Med       Date:  2014-02-09       Impact factor: 4.018

9.  Coping and emotion regulation profiles as predictors of nonmedical prescription drug and illicit drug use among high-risk young adults.

Authors:  Carolyn F Wong; Karol Silva; Aleksandar Kecojevic; Sheree M Schrager; Jennifer Jackson Bloom; Ellen Iverson; Stephen E Lankenau
Journal:  Drug Alcohol Depend       Date:  2013-02-28       Impact factor: 4.492

10.  Wastewater analysis: the mean of the monitoring of frequently prescribed pharmaceuticals in Slovakia.

Authors:  Tomáš Mackuľak; Lucia Birošová; Miroslav Gál; Igor Bodík; Roman Grabic; Jozef Ryba; Jaroslav Škubák
Journal:  Environ Monit Assess       Date:  2015-12-09       Impact factor: 2.513

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.